Dong-A ST Co., Ltd.
Records under this name other than the patents Dong-A ST Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,864,238 | Composition Containing Poria Cocos Peel Extract for Treating Neurodegenerative Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,946,053 | Composition Containing Mixed Extract of Mulberry and Poria Cocos Bark for Preventing, Improving or Treating Neurodegenerative Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,588,927 | Composition Containing Mixed Extract of Mulberry and Poria Cocos Peel Formerly held In force · High confidence | In force | High confidence | |
| US 10,660,928 | Pharmaceutical Composition Containing Combination Extracts of Moutan Root Bark, Angelica Dahurica Root, Bupleurum Root or Fractions Thereof for Prevention and Treatment of Neurodegenerative Disorder Formerly held In force · High confidence | In force | High confidence | |
| US 10,913,730 | Heteroaryl compounds and their use as Mer inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,992,562 | Percutaneous Absorption Preparation for Treating Dementia Comprising Donepezil Formerly held In force · High confidence | In force | High confidence | |
| US 9,822,174 | Anti-VEGF antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same Lapsed on the fee record Ended Nov 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 21, 2025 | From the USPTO record |
| US 9,771,348 | Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |
| US 9,163,043 | Novel Oxazolidinone Derivatives Formerly held Term ended Term ended Dec 17, 2024 · High confidence | Term ended | Term ended Dec 17, 2024 | High confidence |
| US 9,533,977 | Oxazolidinone derivative as CETP inhibitor, its preparation method, and pharmaceutical composition comprising the same Lapsed on the fee record Ended Jan 3, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 3, 2021 | From the USPTO record |